CDKN2A and neoplasm: Reasoning that silencing or mutating Cdkn2a might facilitate in vitro immortalization as it does for other normal and transformed cells, we used in vivo Crispr/Cas9-mediated targeting of Cdkn2a’s exon 2 at the time of tumor initiation [25,122,123,126,159].